Clinical Trials Browser

Phase 3 × OTHER × Persistent Infection × Clear all

NCT01735006 2020-02-24

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Phase 3 Completed

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02562508 2018-08-16

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Phase 3 Completed

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms